 |
Pantoloc
is a proton pump inhibitor PPI, that
suppresses the final step in gastric
acid production. |
|
Pantoloc belongs
to the substituted benzimidazole group.
It is the third proton pump inhibitor
that shows marked improvement in selectivity
and pharmacokinetic properties compared
with omeprazole and lanzoprazole. |
|
Pantoloc
shows great efficacy in treating various
acid-peptic diseases. |
|
Pantoloc
maintains the physiological
pH-rhythm of parietal cells: |
| |
- Pantoloc exerts
its effect in an acidic environment
(pH < 3), and it is mostly
inactive at higher pH.
- Its pharmacological and therapeutic
effect is achieved in the acid-secretory
parietal cells.
|
|
Pantoloc provides
ultra rapid pain relief. |
|
Pantoloc provides
superior symptoms control for 24 hours. |
|
Pantoloc provides
reliable healing rate. |
